Bio-Rad Laboratories (BIO) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.94% |
| Dec 31, 2025 | -9.22% |
| Sep 30, 2025 | -4.21% |
| Jun 30, 2025 | -5.89% |
| Mar 31, 2025 | -9.88% |
| Dec 31, 2024 | -8.35% |
| Sep 30, 2024 | 6.00% |
| Jun 30, 2024 | -22.48% |
| Mar 31, 2024 | 12.57% |
| Dec 31, 2023 | 13.49% |
| Sep 30, 2023 | 11.64% |
| Jun 30, 2023 | -33.35% |
| Mar 31, 2023 | -2.61% |
| Dec 31, 2022 | 10.24% |
| Sep 30, 2022 | -9.44% |
| Jun 30, 2022 | 3.32% |
| Mar 31, 2022 | -25.20% |
| Dec 31, 2021 | -0.66% |
| Sep 30, 2021 | -10.65% |
| Jun 30, 2021 | -22.39% |
| Mar 31, 2021 | -19.25% |
| Dec 31, 2020 | -4.74% |
| Sep 30, 2020 | -7.99% |
| Jun 30, 2020 | -7.23% |
| Mar 31, 2020 | -7.84% |
| Dec 31, 2019 | -21.95% |
| Sep 30, 2019 | 4.21% |
| Jun 30, 2019 | 1.97% |
| Mar 31, 2019 | -6.02% |
| Dec 31, 2018 | -6.77% |
| Sep 30, 2018 | -8.90% |
| Jun 30, 2018 | 13.31% |
| Mar 31, 2018 | 13.18% |
| Dec 31, 2017 | 3.89% |
| Sep 30, 2017 | 17.13% |
| Jun 30, 2017 | 3.11% |
| Mar 31, 2017 | 3.53% |
| Dec 31, 2016 | 10.73% |
| Sep 30, 2016 | 2.39% |
| Jun 30, 2016 | 13.75% |
| Mar 31, 2016 | 11.76% |
| Dec 31, 2015 | 5.10% |
| Sep 30, 2015 | -1.39% |
| Jun 30, 2015 | -0.77% |
| Mar 31, 2015 | -3.51% |
| Dec 31, 2014 | 10.64% |
| Sep 30, 2014 | -4.86% |
| Jun 30, 2014 | -3.95% |